Aelix Therapeutics

Aelix Therapeutics

Aelix Therapeutics

AELIX Therapeutics, a drug development company specialized in the discovery and development of immunotherapies for HIV infection
Founded
2014
Raised
$13.9M
Follow us
Alexa global traffic share
Latest funding
€11,550,000
Undisclosed
Team Size
1–10
Employees
€11,500,000 Venture capital (Series A)
mjt

Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine

€11,500,000 Venture capital (Series A)
FinSMEs

Aelix Therapeutics Closes €11.5M Series A Funding

Health Funding